Drug intelligence / Profile preview

Siriderma

Development stage
Unknown
Lead developer
DR. KADE Health Care
Modality
Small Molecules
Administration
Topical
01

Overview

Siriderma is a line of alkaline (slightly basic) dermocosmetic topical products developed by SIRIUS GmbH, a subsidiary of DR. KADE Pharma. These products are specifically formulated for individuals with dermatological conditions such as atopic dermatitis (neurodermatitis), psoriasis, and extremely dry or sensitive skin. The mechanism of action relies on an alkaline pH approach to soothe the skin, support the natural protective barrier, and promote regeneration. The formulations are vegan and free from alcohol, preservatives, and parabens, utilizing natural ingredients to provide lasting skin care. The product range includes specialized series such as Siriderma Med for problem skin, Siriderma Pure for active care, and Siriderma Care for gentle maintenance. The brand was acquired by DR. KADE Pharma in January 2019 and is manufactured in Germany.

Brand names
SiridermaSiriderma MedSiriderma PureSiriderma Care
Other names
SiridermaSIRIDERMA dermocosmetics

Beyond the preview

Go deeper on Siriderma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Siriderma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call